Cell Cleaning Mechanism Has Dual Role in ALS, Study Finds
A mechanism that cells normally use to keep them healthy was found to have a dual role in amyotrophic lateral…
Articles by Alice Melão
Wave Is Developing Two Drugs That Target a Common ALS Mutation
Wave Life Sciences is developing two ALS and frontotemporal dementia therapies that target a gene mutation common in both. The…
Worldwide Clinical Trials Picked to Manage Phase 3 Study of NurOwn for ALS
Worldwide Clinical Trials was selected as the Clinical Research Organization (CRO) to run a Phase 3 study of the investigational stem-cell…
Radicava and Its Swift FDA Approval Are Reasons for Hope, ALS Association Official Says
Radicava (edaravone), the first approved treatment for amyotrophic lateral sclerosis in 22 years, is being welcomed with “a great…
Transcript of Interview with ALS Association’s Calaneet Balas on Radicava, the FDA, Insurance and Pricing
Below is a transcript of the ALS News Today interview with Calaneet Balas, executive vice president of strategy for the ALS Association.
Edaravone, Now Known as Radicava, Has Been ‘Minor Miracle’ for Some, ALS Worldwide Co-director Says
Edaravone — now more widely known by its U.S. brand name, Radicava — has produced “a minor miracle” for…
Stem Cell Transplantation Shows Potential as ALS Therapy, Study Suggests
Stem cell transplantation in patients with amyotrophic lateral sclerosis (ALS) has the potential to be “an important alternative strategy” in…
Discovery of Molecular Trigger of Motor Neuron Death Could Aid ALS Treatment Research
Researchers have identified the sequence of molecular events leading to motor neuron death in amyotrophic…
Radicava’s Journey to Becoming 1st ALS Treatment in 22 Years, an Interview with MT Pharma America
Radicava, also known by its generic name edaravone, is the first treatment approved by U.S. Food and Drug Administration…
Potential ALS Therapy Based on Cancer Treatment Rituximab Shows Promise
Researchers at Ben-Gurion University (BGU) believe that an existing FDA-approved anti-cancer drug, rituximab, could be modified and used to…